Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

Radiation Oncology

Volumn 3, Issue 1, 2008, Pages

  Ghadjar, Pirus ^a,b   Vock, Jacqueline ^a,b   Vetterli, Daniel ^a,b   Manser, Peter ^a,b   Bigler, Roland ^a,b   Tille, Jan ^a,b   Madlung, Axel ^a,b   Behrensmeier, Frank ^a,b   Mini, Roberto ^a,b   Aebersold, Daniel M ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN;

ACUTE TOXICITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSURIA; GASTROINTESTINAL TOXICITY; HEMATURIA; HUMAN; INCONTINENCE; INTENSITY MODULATED RADIATION THERAPY; MALE; MONOTHERAPY; MORBIDITY; OUTCOME ASSESSMENT; PROSTATE CANCER; RADIATION DETECTION; RADIATION DOSE; RATING SCALE; RECTUM DISEASE; RECTUM HEMORRHAGE; RECURRENCE RISK; RISK ASSESSMENT; SCORING SYSTEM; URINARY URGENCY; URINE RETENTION; UROGENITAL TRACT DISEASE; FOLLOW UP; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RADIATION INJURY; RECURRENT DISEASE; RISK; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECURRENCE; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149339830     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-3-35     Document Type: Article

References (24)

1. Bracarda S de Cobelli O Greco C Prayer-Galetti T Valdagni R Gatta G de Braud F Bartsch G Cancer of the prostate Crit Rev Oncol Haematol 2005, 56:379-396. 10.1016/j.critrevonc.2005.03.010
2. Jemal A Siegel R Ward E Murray T Xu J Smigal C Thun MJ Cancer statistics, 2006 CA Cancer J Clin 2006, 56:106-130. 16514137
3. D' Amico AV Hanks GE Three-dimensional conformal radiation therapy for prostate cancer Radiotherapeutic management of prostate adenocarcinoma Boston: Arnold 1999:21-50.
4. Zelefsky MJ Fuks Z Happersett L Lee HJ Ling CC Burman CM Hunt M Wolfe T Venkatraman ES Jackson A Skwarchuk M Leibel SA Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 2000, 55:241-249. 10.1016/S0167-8140(99)00100-0 10869739
5. Leibel SA Fuks Z Zelefsky MJ Hunt M Burman CM Mageras GS Chui CS Jackson A Amols HI Ling CC Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer Semin Oncol 2003, 30(5):596-615. 10.1016/S0093-7754(03)00354-3 14571409
6. Shipley WU Verhey LJ Munzenrider JE Suit HD Urie MM McManus PL Young RH Shipley JW Zietman AL Biggs PJ et al.: Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 1995, 32:3-12. 7721636
7. Hanks GE Hanlon AL Schultheiss TE Pinover WH Movsas B Epstein BE Hunt MA Dose escalation with 3D conformal treatment: 5 year outcomes, treatment optimization, and future directions Int J Radiat Oncol Biol Phys 1998, 41:501-510. 10.1016/S0360-3016(98)00089-3 9635695
8. Zelefsky MJ Leibel SA Gaudin PB Kutcher GJ Fleshner NE Venkatramen ES Reuter VE Fair WR Ling CC Fuks Z Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 1998, 41:491-500. 10.1016/S0360-3016(98)00091-1 9635694
9. Zelefsky MJ Fuks Z Hunt M Lee HJ Lombardi D Ling CC Reuter VE Venkatraman ES Leibel SA High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 2001, 166:876-881. 10.1016/S0022-5347(05)65855-7 11490237
10. Pollack A Zagars GK Starkschall G Antolak JA Lee JJ Huang E von Eschenbach AC Kuban DA Rosen I Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 2002, 53:1097-1105. 10.1016/S0360-3016(02)02829-8 12128107
11. Sathya JR Davis IR Julian JA Guo Q Daya D Dayes IS Lukka HR Levine M Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 2005, 23:1192-1199. 10.1200/JCO.2005.06.154 15718316
12. Zietman AL DeSilvio ML Slater JD Rossi CJ Jr Miller DW Adams JA Shipley WU Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 2005, 294:1233-1239. 10.1001/ jama.294.10.1233 16160131
13. Boersma LJ Brink van den M Bruce AM Shouman T Gras L te Velde A Lebesque JV Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer using dose-volume histograms Int J Radiat Oncol Biol Phys 1998, 41:83-92. 9588921
14. Storey MR Pollack A Zagars G Smith L Antolak J Rosen I Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 2000, 48:635-42. 11020558
15. Steenbakkers RJ Deurloo KE Nowak PJ Lebesque JV van Herk M Rasch CR Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate Int J Radiat Oncol Biol Phys 2003, 57:1269-79. 14630261
16. Sobin LH Wittekind CH The prostate TNM Classification of Malignant Tumors New York, Wiley-Liss 2002:184-187.
17. Vetterli D Riem H Aebersold DM Greiner RH Manser P Cossmann P Kemmerling L Born EJ Mini R Introduction of a novel dose saving acquisition mode for the PortalVision aS500 EPID to facilitate on-line patient setup verification Med Phys 2004, 31:828-31. 10.1118/1.1668391 15125000
18. Roach M 3rd Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 1993, 150:1923-24. 7693984
19. Vetterli D Thalmann S Behrensmeier F Kemmerling L Born EJ Mini R Greiner RH Aebersold DM Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode Radiother Oncol 2006, 79:101-108. 10.1016/ j.radonc.2006.03.005 16621076
20. Harris EK Albert A Survivorship analysis for clinical studies New York, NY: Marcel Dekker 1991:5-125.
21. Cox DR Oakes D Analysis of survival data London, United Kingdom: Chapman and Hall 1984:110-120.
22. Skala M Rosewall T Dawson L Divanbeigi L Lockwood G Thomas C Crook J Chung P Warde P Catton C Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 2007, 68:690-698. 17379434
23. Lips IM Dehnad H van Gils CH Boeken Kruger AE Heide van der UA van Vulpen M High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: Acute and late toxicity in 331 patients Radiat Oncol 2008, 3:15. 2430572 18495016 10.1186/1748-717X-3-15
24. Lawton CA Bae K Pilepich M Hanks G Shipley W Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: Analysis of Radiation Therapy Oncology Group studies 85-31, 86-10, and 92-02 Int J Radiat Oncol Biol Phys 2008, 70:437-41. 17881145